These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 38794231)

  • 1. Small Molecule Drugs Targeting Viral Polymerases.
    Palazzotti D; Sguilla M; Manfroni G; Cecchetti V; Astolfi A; Barreca ML
    Pharmaceuticals (Basel); 2024 May; 17(5):. PubMed ID: 38794231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-nucleoside Inhibitors of Zika Virus RNA-Dependent RNA Polymerase.
    Gharbi-Ayachi A; Santhanakrishnan S; Wong YH; Chan KWK; Tan ST; Bates RW; Vasudevan SG; El Sahili A; Lescar J
    J Virol; 2020 Oct; 94(21):. PubMed ID: 32796069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Broad-spectrum non-nucleoside inhibitors for caliciviruses.
    Netzler NE; Enosi Tuipulotu D; Eltahla AA; Lun JH; Ferla S; Brancale A; Urakova N; Frese M; Strive T; Mackenzie JM; White PA
    Antiviral Res; 2017 Oct; 146():65-75. PubMed ID: 28757394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of SARS-CoV-2 polymerase by nucleotide analogs from a single-molecule perspective.
    Seifert M; Bera SC; van Nies P; Kirchdoerfer RN; Shannon A; Le TT; Meng X; Xia H; Wood JM; Harris LD; Papini FS; Arnold JJ; Almo S; Grove TL; Shi PY; Xiang Y; Canard B; Depken M; Cameron CE; Dulin D
    Elife; 2021 Oct; 10():. PubMed ID: 34617885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of viral RNA polymerases by nucleoside and nucleotide analogs: therapeutic applications against positive-strand RNA viruses beyond hepatitis C virus.
    Deval J; Symons JA; Beigelman L
    Curr Opin Virol; 2014 Dec; 9():1-7. PubMed ID: 25194816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiviral therapy targeting viral polymerase.
    Tsai CH; Lee PY; Stollar V; Li ML
    Curr Pharm Des; 2006; 12(11):1339-55. PubMed ID: 16611119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The antiviral activity and mechanism of action of (S)-[3-hydroxy-2-(phosphonomethoxy)propyl] (HPMP) nucleosides.
    Magee WC; Evans DH
    Antiviral Res; 2012 Nov; 96(2):169-80. PubMed ID: 22960154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progression of Antiviral Agents Targeting Viral Polymerases.
    Peng S; Wang H; Wang Z; Wang Q
    Molecules; 2022 Oct; 27(21):. PubMed ID: 36364196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two-Metal Ion-Dependent Enzymes as Potential Antiviral Targets in Human Herpesviruses.
    DiScipio KA; Weerasooriya S; Szczepaniak R; Hazeen A; Wright LR; Wright DL; Weller SK
    mBio; 2022 Feb; 13(1):e0322621. PubMed ID: 35073739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current Strategies of Antiviral Drug Discovery for COVID-19.
    Mei M; Tan X
    Front Mol Biosci; 2021; 8():671263. PubMed ID: 34055887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RdRp inhibitors and COVID-19: Is molnupiravir a good option?
    Hashemian SMR; Pourhanifeh MH; Hamblin MR; Shahrzad MK; Mirzaei H
    Biomed Pharmacother; 2022 Feb; 146():112517. PubMed ID: 34902743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of viral RNA-dependent RNA polymerases with clinically relevant nucleotide analogs.
    Maheden K; Todd B; Gordon CJ; Tchesnokov EP; Götte M
    Enzymes; 2021; 49():315-354. PubMed ID: 34696837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small-Molecule Antiviral β-d-
    Agostini ML; Pruijssers AJ; Chappell JD; Gribble J; Lu X; Andres EL; Bluemling GR; Lockwood MA; Sheahan TP; Sims AC; Natchus MG; Saindane M; Kolykhalov AA; Painter GR; Baric RS; Denison MR
    J Virol; 2019 Dec; 93(24):. PubMed ID: 31578288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advancements in the discovery of small-molecule non-nucleoside inhibitors targeting SARS-CoV-2 RdRp.
    Zhou B; Chen D; Zhang T; Song C; Zhang X; Lin L; Huang J; Peng X; Liu Y; Wu G; Li J; Chen W
    Biomed Pharmacother; 2024 Feb; 171():116180. PubMed ID: 38266622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Herpesvirus DNA polymerases: Structures, functions and inhibitors.
    Zarrouk K; Piret J; Boivin G
    Virus Res; 2017 Apr; 234():177-192. PubMed ID: 28153606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resistance to a Nucleoside Analog Antiviral Drug from More Rapid Extension of Drug-Containing Primers.
    Chen H; Lawler JL; Filman DJ; Hogle JM; Coen DM
    mBio; 2021 Feb; 12(1):. PubMed ID: 33563814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A review: Mechanism of action of antiviral drugs.
    Kausar S; Said Khan F; Ishaq Mujeeb Ur Rehman M; Akram M; Riaz M; Rasool G; Hamid Khan A; Saleem I; Shamim S; Malik A
    Int J Immunopathol Pharmacol; 2021; 35():20587384211002621. PubMed ID: 33726557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New antiviral approaches for respiratory syncytial virus and other mononegaviruses: Inhibiting the RNA polymerase.
    Fearns R; Deval J
    Antiviral Res; 2016 Oct; 134():63-76. PubMed ID: 27575793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The development of broad-spectrum antiviral medical countermeasures to treat viral hemorrhagic fevers caused by natural or weaponized virus infections.
    Hickman MR; Saunders DL; Bigger CA; Kane CD; Iversen PL
    PLoS Negl Trop Dis; 2022 Mar; 16(3):e0010220. PubMed ID: 35259154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An RNA Hybridization Assay for Screening Influenza A Virus Polymerase Inhibitors Using the Entire Ribonucleoprotein Complex.
    Roch FF; Hinterkörner G; Menke J; Tang GQ; Cusack S; Butzendobler B; Buschmann H; Datta K; Wolkerstorfer A
    Assay Drug Dev Technol; 2015 Oct; 13(8):488-506. PubMed ID: 26461433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.